4,4'-(5'-(4-(3,5-Dimethyl-1H-pyrazol-4-yl)phenyl)-[1,1':3',1''-terphenyl]-4,4''-diyl)bis(3,5-dimethyl-1H-pyrazole)

Catalog No. :
ACTKSI605
CAS No. :
1874148-68-1
Molecular Formula :
C39H36N6
Molecular Weight :
588.76

IUPAC Name:4,4'-(5'-(4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl)-[1,1':3',1''-terphenyl]-4,4''-diyl)bis(3,5-dimethyl-1H-pyrazole)

4,4'-(5'-(4-(3,5-Dimethyl-1H-pyrazol-4-yl)phenyl)-[1,1':3',1''-terphenyl]-4,4''-diyl)bis(3,5-dimethyl-1H-pyrazole) structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,4'-(5'-(4-(3,5-Dimethyl-1H-pyrazol-4-yl)phenyl)-[1,1':3',1''-terphenyl]-4,4''-diyl)bis(3,5-dimethyl-1H-pyrazole)
IUPAC Name4,4'-(5'-(4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl)-[1,1':3',1''-terphenyl]-4,4''-diyl)bis(3,5-dimethyl-1H-pyrazole)
Molecular FormulaC39H36N6
Molecular Weight588.76
SMILESCC1=C(C2=CC=C(C3=CC(C4=CC=C(C5=C(C)NN=C5C)C=C4)=CC(C6=CC=C(C7=C(C)NN=C7C)C=C6)=C3)C=C2)C(C)=NN1
InChI KeyDQPNGJPKPJDARA-UHFFFAOYSA-N
Synonym1,3,5-tri[4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl]benzene;4,4'-(5'-(4-(3,5-dimethyl-1H-pyrazol-4-yl)phenyl)-[1,1':3',1''-terphenyl]-4,4''-diyl)bis(3,5-dimethyl-1H-pyrazole)
CAS No.1874148-68-1

Synthetic Route by SureRoute

1. ACTKSI605 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACISQH920 route compound structure diagram
    ACISQH920857530-80-4 In Stock
  4. Then
  5. ACTKSI605 route product structure diagram
    ACTKSI6051874148-68-1
Inquiry

2. ACTKSI605 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTKSI605 route product structure diagram
    ACTKSI6051874148-68-1
Inquiry

Comments (0)